Media outlets ignore objections from public health experts on FDA emergency use authorization of convalescent plasma | Media Matters for America

Plasma MSM

Under pressure from the Trump White House on the eve of the Republican National Convention, the Food and Drug Administration issued an emergency use authorization yesterday for a potential therapeutic against COVID-19. But mainstream news coverage of the announcement largely ignored objections from public health experts that critical data needed to justify this move from the FDA is missing.

Media outlets ignore objections from public health experts on FDA emergency use authorization of convalescent plasma | Media Matters for America